01
Who We Are
Deeply integrated,
deeply invested
Relay Therapeutics' Approach
Relay Therapeutics was built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights are driven by our Dynamo platform, which integrates an array of leading-edge experimental and computational approaches and enables us to effectively drug protein targets that have previously been intractable or inadequately addressed.
Three important forces led to the
founding of Relay Therapeutics:
Genomic Data
Computational
Experimental
Genomic Data
The genomic revolution has enabled a better understanding of the targets that drive disease, and which patients may benefit from new targeted therapies.
1999
2003
2009
2012
2016
Late 1990s
2007
2012
2014
2004
2012
2003
2016
Experimental Resolution
Structural biology techniques emerged that finally allow scientists to visualize protein motion at atomic resolutions.
Computational Power and Speed
Technology improved to the point that molecular dynamics simulations can be run on proteins at biologically relevant timescales useful for drug discovery.
2016
We are advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology and genetic disease.